Literature DB >> 16036112

The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.

Rosalind M Glasspool1, Sharon Burns, Stacey F Hoare, Catharina Svensson, W Nicol Keith.   

Abstract

Telomerase plays a role in the unlimited replicative capacity of the majority of cancer cells and provides a potential anticancer target. The regulation of telomerase is complex but transcriptional control of its two essential components, hTERC (RNA component) and hTERT (reverse transcriptase component), is of major importance. To investigate this further, we have used the adenoviral protein, E1A, as a tool to probe potential pathways involved in the control of telomerase transcription. The second exon of the adenoviral protein E1A activates both telomerase gene promoters in transient transfections. The corepressor, C terminal binding protein, is one of only two proteins known to bind to this region, and we propose that E1A activates both promoters by sequestering CtBP, thereby relieving repression. Activation by exon 2 of E1A involves the SP1 sites in both promoters, and consistent with this, SP1 and CtBP interact in coimmunoprecipitation studies. Modulation of the chromatin environment has been implicated in the regulation of hTERT transcription and appears to involve the SP1 sites. CtBP can be found within a histone-modifying complex and it is possible that a CtBP complex, associating with the SP1 sites, represses transcription from the telomerase promoters by modifying chromatin structure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036112      PMCID: PMC1501281          DOI: 10.1593/neo.04766

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  72 in total

1.  Coordinated histone modifications mediated by a CtBP co-repressor complex.

Authors:  Yujiang Shi; Jun-ichi Sawada; Guangchao Sui; El Bachir Affar; Johnathan R Whetstine; Fei Lan; Hidesato Ogawa; Margaret Po-Shan Luke; Yoshihiro Nakatani; Yang Shi
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

2.  Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene.

Authors:  Jiangqin Zhao; Alan Bilsland; Stacey F Hoare; W Nicol Keith
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

3.  Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.

Authors:  Alan E Bilsland; Claire J Anderson; Aileen J Fletcher-Monaghan; Fiona McGregor; T R Jeffry Evans; Ian Ganly; Richard J Knox; Jane A Plumb; W Nicol Keith
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

4.  Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation.

Authors:  N Billon; D Carlisi; M B Datto; L A van Grunsven; A Watt; X F Wang; B B Rudkin
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

5.  Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases.

Authors:  Z Zhang; M M Smith; J S Mymryk
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

6.  Human endothelial cell life extension by telomerase expression.

Authors:  J Yang; E Chang; A M Cherry; C D Bangs; Y Oei; A Bodnar; A Bronstein; C P Chiu; G S Herron
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

7.  Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter.

Authors:  Daeyoup Lee; Hak-Zoo Kim; Kwi Wan Jeong; Young Sam Shim; Izumi Horikawa; J Carl Barrett; Joonho Choe
Journal:  J Biol Chem       Date:  2002-05-17       Impact factor: 5.157

8.  Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.

Authors:  D Xu; Q Wang; A Gruber; M Björkholm; Z Chen; A Zaid; G Selivanova; C Peterson; K G Wiman; P Pisa
Journal:  Oncogene       Date:  2000-10-26       Impact factor: 9.867

9.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

10.  Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells.

Authors:  Jaejoon Won; Jeongbin Yim; Tae Kook Kim
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

View more
  11 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression.

Authors:  Yuan Yao; Marcia Bellon; Shary N Shelton; Christophe Nicot
Journal:  J Biol Chem       Date:  2012-04-10       Impact factor: 5.157

3.  Lyon IARC Polyomavirus Displays Transforming Activities in Primary Human Cells.

Authors:  Assunta Venuti; Maria Carmen Romero-Medina; Giusi Melita; Maria Grazia Ceraolo; Rosario Nicola Brancaccio; Cecilia Sirand; Valerio Taverniti; Renske Steenbergen; Tarik Gheit; Massimo Tommasino
Journal:  J Virol       Date:  2022-06-30       Impact factor: 6.549

4.  Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer.

Authors:  Fariborz Rashid-Kolvear; Melania Pintilie; Susan J Done
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

5.  The regulation of telomerase in oncogenesis.

Authors:  D A Skvortzov; M P Rubzova; M E Zvereva; F L Kiselev; O A Donzova
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

6.  RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth.

Authors:  Yu Qin; Wangbing Chen; Yao Xiao; Wendan Yu; Xin Cai; Meng Dai; Tingting Xu; Wenlin Huang; Wei Guo; Wuguo Deng; Taihua Wu
Journal:  Oncotarget       Date:  2015-09-29

7.  TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.

Authors:  Deepa Rajagopalan; Amit Kumar Pandey; Magdalene Claire Xiuzhen; Kwok Kin Lee; Shainan Hora; Yanzhou Zhang; Boon Haow Chua; Hui Si Kwok; Shreshtha Sailesh Bhatia; Lih Wen Deng; Daniel G Tenen; Dennis Kappei; Sudhakar Jha
Journal:  PLoS Pathog       Date:  2017-10-18       Impact factor: 6.823

8.  C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Int J Cell Biol       Date:  2013-05-20

9.  A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1.

Authors:  Brittney-Shea Herbert; Brenda R Grimes; Wei Min Xu; Michael Werner; Christopher Ward; Sandro Rossetti; Peter Harris; Elsa Bello-Reuss; Heather H Ward; Caroline Miller; Vincent H Gattone; Carrie L Phillips; Angela Wandinger-Ness; Robert L Bacallao
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

Review 10.  Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.

Authors:  Muhammad Khairul Ramlee; Jing Wang; Wei Xun Toh; Shang Li
Journal:  Genes (Basel)       Date:  2016-08-18       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.